Eficacitatea cremei SPONDI-LIZ (Newtone Laboratories SRL, România) în osteoartroza deformantă / gonartroză (rezultatele evaluării WOMAC )

Abstract

High clinical efficacy, safety, tolerance and lack of adverse effects during treatment with SPONDI-LIZ cream has been demonstrated in 140 patients with deforming osteoarthrosis based on WOMAC scale evaluation. Analysis of the “Pain” WOMAC section revealed an improvement of 1-8 points, averaging 3.91±1.13 points after 4 weeks of treatment (representing 10-72.7% from the baseline). „Stiffness” section has improved with 0-2 points (1,79±0,59 points or 42,26±14,92%). „Physical functioning” has increased with 11-26 points (14,96±1,83 points or 42,35±5,11%).